Association between molecular monitoring and long-term outcomes in chronic myelogenous leukemia patients treated with first line imatinib

SL Goldberg, L Chen, A Guerin… - … medical research and …, 2013 - Taylor & Francis
Objective: Molecular monitoring using quantitative polymerase chain reaction (qPCR) of
BCR-ABL mRNA transcripts using the international scale (IS) is recommended by the …

Association between molecular monitoring and long-term outcomes in chronic myelogenous leukemia patients treated with first line imatinib.

SL Goldberg, L Chen, A Guerin… - Current Medical …, 2013 - europepmc.org
Objective Molecular monitoring using quantitative polymerase chain reaction (qPCR) of
BCR-ABL mRNA transcripts using the international scale (IS) is recommended by the …

Association between molecular monitoring and long-term outcomes in chronic myelogenous leukemia patients treated with first line imatinib

SL Goldberg, L Chen, A Guerin… - Current medical …, 2013 - pubmed.ncbi.nlm.nih.gov
Objective Molecular monitoring using quantitative polymerase chain reaction (qPCR) of
BCR-ABL mRNA transcripts using the international scale (IS) is recommended by the …

[引用][C] Association between molecular monitoring and long-term outcomes in chronic myelogenous leukemia patients treated with first line imatinib

SL GOLDBERG, LEI CHEN, A GUERIN… - Current medical …, 2013 - pascal-francis.inist.fr
Association between molecular monitoring and long-term outcomes in chronic
myelogenous leukemia patients treated with first line imatinib CNRS Inist Pascal-Francis …